These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 827936)

  • 1. [Aerosol therapy with Mesna in pneumology (Mistabron ucb) (author's translation)].
    Goossens E
    Acta Tuberc Pneumol Belg; 1976; 67(3-4):200-6. PubMed ID: 827936
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical studies on the mucolytic effect of mesna.
    Tekeres M; Horváth A; Bárdosi L; Kenyeres P
    Clin Ther; 1981; 4(1):56-60. PubMed ID: 6791825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of the clinical usefulness of the preparation Mesna (Mucofluid, Mistabron) produced by UCB in treatment of certain laryngological diseases (author's transl)].
    Semczuk B; Gołabek W; Kłos A; Horoch A; Siwiec H; Kupisz K
    Otolaryngol Pol; 1980; 34(6):553-8. PubMed ID: 6782535
    [No Abstract]   [Full Text] [Related]  

  • 4. Mistabron in the intensive care unit.
    Van De Walle J; Lauwers P; Adriaensen H
    Acta Anaesthesiol Belg; 1976; 27 suppl():319-21. PubMed ID: 827913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled trial of intermittent aerosol therapy with sodium 2-mercaptoethane sulphonate in cystic fibrosis.
    Weller PH; Ingram D; Preece MA; Matthew DJ
    Thorax; 1980 Jan; 35(1):42-6. PubMed ID: 6767295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of mucolytic and bronchodilator aerosol therapy on airway resistance in mechanically ventilated patients.
    Zandstra DF; Stoutenbeek CP; Miranda DR
    Intensive Care Med; 1985; 11(6):316-8. PubMed ID: 3936867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro assessment of combined antibiotic and mucolytic treatment for Pseudomonas aeruginosa infection in cystic fibrosis.
    Heaf DP; Webb GJ; Matthew DJ
    Arch Dis Child; 1983 Oct; 58(10):824-6. PubMed ID: 6416185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal encephalopathy with ifosfamide/mesna.
    Verdeguer A; Castel V; Esquembre C; Ferris J; Fernandez JM; Ruiz JG
    Pediatr Hematol Oncol; 1989; 6(4):383-5. PubMed ID: 2518327
    [No Abstract]   [Full Text] [Related]  

  • 9. False positive reaction for urinary ketones with mesna.
    Ben Yehuda A; Heyman A; Steiner-Salz D
    Drug Intell Clin Pharm; 1987 Jun; 21(6):547-8. PubMed ID: 3111808
    [No Abstract]   [Full Text] [Related]  

  • 10. Ifosfamide and mesna.
    Schoenike SE; Dana WJ
    Clin Pharm; 1990 Mar; 9(3):179-91. PubMed ID: 2107997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mercaptoethane sulphonate in cystinic calculosis therapy.
    Di Silverio F; Gallucci M; Ricciuti GP; Alpi G; Fini D; Cassanelli A; Molinari C
    Contrib Nephrol; 1987; 58():193-5. PubMed ID: 3121253
    [No Abstract]   [Full Text] [Related]  

  • 12. Mistabron effects on platelets and blood coagulation.
    Henry RL; Washnock MA; Taylor GW
    J Int Med Res; 1984; 12(5):277-80. PubMed ID: 6437891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ifosfamide/mesna related encephalopathy: a case report with a possible role of phenobarbital in enhancing neurotoxicity.
    Ghosn M; Carde P; Leclerq B; Flamant F; Friedman S; Droz JP; Hayat M
    Bull Cancer; 1988; 75(4):391-2. PubMed ID: 3132998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesna and bone-marrow transplantation.
    Becher R; Kakati S; Sandberg AA
    N Engl J Med; 1982 Oct; 307(18):1152. PubMed ID: 6811895
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative investigation on sputum viscosity before and after administration of mistabron or physiological saline solution with and without physiotherapy (vibration-therapy) (author's transl)].
    Maesen F; Brombacher PJ; Buytendijk HJ; Janssen HC
    Acta Tuberc Pneumol Belg; 1974; 65(2):212-8. PubMed ID: 4371451
    [No Abstract]   [Full Text] [Related]  

  • 16. Ifosfamide and Mesna in advanced malignancies.
    Li GC; Brock N; Li JQ; Guan ZZ; He YJ
    Chin Med J (Engl); 1988 Mar; 101(3):213-20. PubMed ID: 3136996
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of mesna on cyclophosphamide.
    Garrick CL; Cronin SM; Sensenbrenner LL
    DICP; 1989 Oct; 23(10):798-9. PubMed ID: 2510409
    [No Abstract]   [Full Text] [Related]  

  • 18. [Delayed allergy following mesna].
    Frosch PJ; Weickel R; Deboben A; Hunstein W
    Dtsch Med Wochenschr; 1986 Dec; 111(49):1901-2. PubMed ID: 3096684
    [No Abstract]   [Full Text] [Related]  

  • 19. Nursing implications in the administration of ifosfamide and mesna.
    Richters JE
    Oncol Nurs Forum; 1990; 17(2):276. PubMed ID: 2107534
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase II trial of ifosfamide/mesna in metastatic adult renal carcinoma.
    De Forges A; Droz JP; Ghosn M; Theodore C
    Cancer Treat Rep; 1987 Nov; 71(11):1103. PubMed ID: 3119203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.